Lataa...
Targeting treatment options for castration-resistant prostate cancer
Prostate cancer (PCa) is the most commonly diagnosed solid tumor and the second leading cause of cancer-related deaths in U.S. men in 2020. Androgen-deprivation therapy (ADT) is the standard of care for metastatic PCa. Unfortunately, PCa relapse often occurs one to two years after initiation of ADT,...
Tallennettuna:
| Julkaisussa: | Am J Clin Exp Urol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
e-Century Publishing Corporation
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8012826/ https://ncbi.nlm.nih.gov/pubmed/33816699 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|